sc002 and Carcinoma--Hepatocellular

sc002 has been researched along with Carcinoma--Hepatocellular* in 1 studies

Other Studies

1 other study(ies) available for sc002 and Carcinoma--Hepatocellular

ArticleYear
Phototoxic drug reaction with the novel agent rovalpituzumab tesirine.
    International journal of dermatology, 2018, Volume: 57, Issue:3

    Topics: Administration, Topical; Adult; Antibodies, Monoclonal, Humanized; Benzodiazepinones; Biopsy, Needle; Carcinoma, Hepatocellular; Clobetasol; Dermatitis, Phototoxic; Drug Eruptions; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunoconjugates; Immunohistochemistry; Liver Neoplasms; Treatment Outcome

2018